Please login to the form below

Not currently logged in
Email:
Password:

Pletal

This page shows the latest Pletal news and features for those working in and with pharma, biotech and healthcare.

Otsuka’s Pletal has use restricted in Europe

Otsuka’s Pletal has use restricted in Europe

Otsuka’ s Pletal has use restricted in Europe. EMA recommends drug only be used in limited group of patients with blood supply disorder. ... Dr Giuseppe Di Benedetto, senior VP medical affairs and compliance at Otsuka commented on the restricted use of

Latest news

  • New accounts: March

    Pletal. Pain. Brand(x). Pfizer. Celebrex. Pain. Medicus London. sanofi-aventis. Eloxatin. Oncology.

  • New accounts: April

    HRT. Langland. Orion Pharma. Indivina. HRT. Langland. Otsuka Pharmaceuticals. Pletal. Pain.

  • Lovely jubbly bubbly

    What a shame. 1 glass of champagne. PLETAL- cardiovascular.

  • Communiqué Awards 2008: Results

    Agency:Brand(x). Client:Otsuka Pharmaceuticals UK. Campaign:Pletal Five-Star Campaign. Agency:Huntsworth Health. Client:sanofi-aventis and Bristol-Myers Squibb.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics